Evidence map›Paper›PMID 40320739›Full record

Trial reportJournal of the International Society of Sports Nutrition2025

Caffeine's influence on vertical jump height: a real-life collegiate student-athlete approach.

Zacharias Papadakis, Vassilios Panoutsakopoulos, Antonella Schwarz, Jose Antonio

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of the International Society of Sports Nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Effects of Caffeine on NFL Combine-Like Tests in Undergraduate Students.International journal of exercise science · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zacharias PapadakisBarry University, Human Performance Laboratory, Department of Health Promotion and Clinical Practice, Miami Shores, FL, USA.ORCID 0000-0001-8437-8067
Vassilios PanoutsakopoulosAristotle University of Thessaloniki, Biomechanics Laboratory, School of Physical Education and Sport Science at Thessaloniki, Thessaloniki, Greece.ORCID 0000-0002-9832-0314
Antonella SchwarzBarry University, Human Performance Laboratory, Department of Health Promotion and Clinical Practice, Miami Shores, FL, USA.ORCID 0009-0000-7409-2516
Jose AntonioNova Southeastern University, Department of Health and Human Performance, Davie, FL, USA.ORCID 0000-0002-8930-1058

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCaffeine's ergogenic potential in vertical jumping remains contested, particularly at dosages compliant with collegiate athletic regulations. The NCAA enforces a caffeine urinary threshold equivalent to ~5 mg/kg body mass, yet evidence supporting its efficacy in enhancing explosive performance among trained athletes is inconsistent. This study examined whether acute caffeine ingestion at this threshold improves squat jump (SJ) and countermovement jump (CMJ) performance in NCAA Division II student-athletes, while exploring sex-specific responses and trial-to-trial variability.

methodsForty NCAA Division II athletes (18 females, 22 males; 21.3 ± 2.4 years) participated in a single-blind, randomized, crossover trial. Participants ingested 5 mg/kg caffeine or placebo, followed by SJ and CMJ testing on a force platform 60 minutes post-consumption. Three trials per jump type were retained to preserve intra-individual variance. Linear mixed-effects models (LMMs) assessed fixed effects of condition, sex, and trials, with random intercepts and slopes accounting for individual variability. A priori power analyses guided sample size determination, targeting sensitivity to detect small-to-medium effects (Cohen's f ≥ 0.2).

resultsCaffeine elicited trivial, non-significant differences in SJ (β =  -0.24 cm,

conclusionsA 5 mg/kg caffeine dose, compliant with NCAA thresholds, did not enhance vertical jump performance in habituated collegiate athletes, challenging prior assertions of its universal ergogenicity for ballistic tasks. While sex differences in baseline performance persisted, caffeine did not modulate these disparities, implicating neuromuscular and anthropometric factors as primary determinants. The absence of ergogenic effects aligns with NCAA safety-focused policies but highlights the need for personalized dosing strategies and research into higher doses, genetic variability, and hormonal influences. Future studies should integrate biomechanical metrics and controlled hormonal assessments to elucidate caffeine's nuanced role in anaerobic power sports.

Indexed as

Athletic PerformanceCaffeinePerformance-Enhancing SubstancesAthletesCross-Over StudiesFemaleHumansMaleSex FactorsSingle-Blind MethodStudentsUniversitiesYoung AdultCaffeinePerformance-Enhancing Substancesergogenic aidslinear mixed modelsNCAAsex differences

Identifiers

PMID40320739
PMCPMC12054566

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.